Skip to main content

Becton Dickinson and Company(BDX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low264.03
Day High266.82
Open:264.46
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Reports for Becton Dickinson and Company

News for Becton Dickinson and Company

Select a category then submit the form to load news
PR Newswire
BD Ranks in Top 10 for Transparency, Awarded Best Code of Conduct in 2023 U.S. Transparency Awards
PR Newswire
Navigate BioPharma Services, Inc. Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development
The Globe and Mail
Six health care stock picks to play defence in times of market volatility
PR Newswire
BD to Present at Investor Healthcare Conferences
PR Newswire
BD Reports Third Quarter Fiscal 2023 Financial Results
PR Newswire
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
PR Newswire
BD Board Declares Dividend
Barchart
Stocks End Moderately Higher as Earnings Season Heats Up
PR Newswire
BD Names Joanne Waldstreicher to Board of Directors
Motley Fool
Why Shares of Becton, Dickinson Rose Monday
Barchart
Stocks Post Moderate Gains on Strength in Energy Stocks and Lower Bond Yields
PR Newswire
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris™ Infusion System
Barchart
Stocks Set to Open Higher as Investors Await Fed Meeting, Big Tech Earnings
PR Newswire
BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System
PR Newswire
BD Issues FY 2022 ESG Report, Highlights Notable Progress in Energy and Waste Reduction, Health Care Access and Diversity
PR Newswire
BD Recognized as a Best Place to Work for Disability Inclusion
PR Newswire
BD to Announce Financial Results for its Third Quarter of Fiscal 2023
PR Newswire
BD to Sell Surgical Instrumentation Platform to STERIS
PR Newswire
BD Launches New Robotic System to Automate Clinical Flow Cytometry
PR Newswire
BCAL Findings Presented at 2023 ASCO Annual Meeting
MarketBeat
Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs
PR Newswire
BD Advances Prefilled Flush Syringe with Integrated 'Scrub-the-Hub' Innovation
PR Newswire
BD Launches World's First Spectral Cell Sorter with High-Speed Cell Imaging
PR Newswire
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics
PR Newswire
Health Care Collaboration in Denmark Aims to Reduce Medical Waste
PR Newswire
BCAL DIAGNOSTICS OPENS NEW LABORATORY IN SYDNEY AS IT ACCELERATES DEVELOPMENT OF ITS BREAST CANCER BLOOD SCREENING TOOL
PR Newswire
BD Reports Second Quarter Fiscal 2023 Financial Results
PR Newswire
BD Recognized by DiversityInc as a Top U.S. Company for Diversity in 2023 List
PR Newswire
BD to Present at Bank of America Securities 2023 Health Care Conference
PR Newswire
BD Board Declares Dividend
PR Newswire
BD Recognized by Forbes as a Best Employer for Diversity in 2023 List
PR Newswire
New Harris Poll Finds Women Want More Education on Sexually Transmitted Infections Testing and Treatment
More Becton Dickinson and Company news

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.